No Data
No Data
Express News | Emergent BioSolutions Receives NAI Status For Baltimore Bayview Manufacturing Facility
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
GAITHERSBURG, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced that the U.S. Food and Drug Administration (FDA) has listed "No Action Indicated" or NAI status classification for
Sector Update: Health Care Stocks Higher in Afternoon Trading
Health care stocks rose Tuesday afternoon with the NYSE Health Care Index increasing 0.6% and the Health Care Select Sector SPDR Fund (XLV) gaining 0.5%.
Emergent BioSolutions Tumbles After S&P Global Credit Downgrade
Emergent BioSolutions (EBS) shares slumped Tuesday after S&P Global Ratings cut its credit rating for the vaccine manufacturer deeper below investment grade, saying the company may not be able to refi
Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
Express News | Emergent Biosolutions Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results and Issued FY24 Revenue Guidance Below Estimates
No Data